Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001493152-16-012492

← back to feed
Filed
Aug 15, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 12, 2016 14.2M sh
Operating Cash Flow Q2 2016 · Jun 30, 2016 −$503.2K
Operating Cash Flow Q2 2016 · Jun 30, 2015 −$851.21K
Stockholders Equity Q2 2016 · Jun 30, 2016 $359.15K
Stockholders Equity Q2 2016 · Dec 31, 2015 $388.14K
Current Liabilities Q2 2016 · Jun 30, 2016 $283.24K
Current Liabilities Q2 2016 · Dec 31, 2015 $309.8K
Current Assets Q2 2016 · Jun 30, 2016 $642.39K
Current Assets Q2 2016 · Dec 31, 2015 $697.93K
Total Assets Q2 2016 · Jun 30, 2016 $642.39K
Total Assets Q2 2016 · Dec 31, 2015 $697.93K
Sga Expense Q2 2016 · Jun 30, 2016 $31.26K
Sga Expense Q2 2016 · Jun 30, 2016 $67.66K
Sga Expense Q2 2016 · Jun 30, 2015 $69.73K
Sga Expense Q2 2016 · Jun 30, 2015 $120.27K
Rd Expense Q2 2016 · Jun 30, 2016 $137.66K
Rd Expense Q2 2016 · Jun 30, 2016 $208.6K
Rd Expense Q2 2016 · Jun 30, 2015 $193.14K
Rd Expense Q2 2016 · Jun 30, 2015 $409.65K
Net Income Q2 2016 · Jun 30, 2016 −$685.58K
Net Income Q2 2016 · Jun 30, 2016 −$1.08M
Net Income Q2 2016 · Jun 30, 2015 −$440.68K
Net Income Q2 2016 · Jun 30, 2015 −$886.15K
Operating Income Q2 2016 · Jun 30, 2016 −$683.48K
Operating Income Q2 2016 · Jun 30, 2016 −$1.08M
Operating Income Q2 2016 · Jun 30, 2015 −$447.75K
Operating Income Q2 2016 · Jun 30, 2015 −$899.84K